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ABSTRACT 
Using annual time series data on the total number of new HIV infections in Togo from 1990 – 2018, the study makes 
predictions for the period 2019 – 2030. The research applies the Box-Jenkins ARIMA methodology. The diagnostic ADF 
tests show that, J, the series under consideration is an I (2) variable. Based on the AIC, the study presents the ARIMA (0, 2, 
2) model as the optimal model. The diagnostic tests further indicate that the presented model is indeed stable and its residuals 
are not serially correlated and are also normally distributed. The results of the study indicate that the total number of new 
HIV infections in Togo is projected to decline sharply by 53.5% from the estimated 4791 new infections in 2019 to 
approximately 2229 new infections by 2030.  
 
1. INTRODUCTION 
The Acquired Immunodeficiency Syndrome (AIDS) is a disease caused by the Human Immunodeficiency Virus (HIV) 
which is currently a global pandemic (UNAIDS, 2008). HIV infection continues to be a public health problem in Sub-
Saharan Africa, where at least 25.6 million people already live with HIV, although there has been a reduction in new 
infections of HIV of about 41% between 2000 and 2015 (Yaya et al., 2018). The decline in the incidence of HIV infection 
is the effect of multiple interventions implemented to prevent HIV transmission among heterosexual and especially from 
mother-to-child HIV transmission (UNAIDS, 2016). HIV prevalence is Togo is now around 3.2% (UNAIDS, 2008). The 
main goal of this study is to predict the number of new HIV infections in Togo over the period 2019 – 2030. This piece of 
work will go a long way in assessing the possibility of ending the HIV scourge in the country. 
 
2. LITERATURE REVIEW 
 
Landoh et al. (2014) conducted a systematic review and concluded that HIV incidence in Togo remains high, especially in 
key risk populations. Consistently, Djibril et al. (2015) described both the epidemiology and prognosis of people living 
with HIV (PLHIV) in intensive care. The study basically found out that the proportion of patients with HIV infection is 
high in medical intensive care units in Togo. In a Zimbabwean study, Nyoni & Nyoni (2019) assessed new HIV infections 
in the rural community of Silobela. The research showed that new HIV infections in the community of Silobela will 
continue to decline over the period 2019 to 2021. No similar study has been in Togo, this study is the first its kind in the 
country.  
3. METHODODOLOGY 
3.1 The Box – Jenkins (1970) Methodology 
The first step towards model selection is to difference the series in order to achieve stationarity. Once this process is over, 
the researcher will then examine the correlogram in order to decide on the appropriate orders of the AR and MA 
components. It is important to highlight the fact that this procedure (of choosing the AR and MA components) is biased 
towards the use of personal judgement because there are no clear – cut rules on how to decide on the appropriate AR and 
MA components. Therefore, experience plays a pivotal role in this regard. The next step is the estimation of the tentative 
model, after which diagnostic testing shall follow. Diagnostic checking is usually done by generating the set of residuals 
and testing whether they satisfy the characteristics of a white noise process. If not, there would be need for model re – 
specification and repetition of the same process; this time from the second stage. The process may go on and on until an 
appropriate model is identified (Nyoni, 2018c). This approach will be used to analyze, J, the series under consideration.  
3.2 The Applied Box – Jenkins ARIMA Model Specification 










+ 𝜇𝑡………………………… . . ……………… .………………[1] 
where ∆ is the difference operator, vector β ϵ Ɽp and ɑ ϵ Ɽq. 
3.3 Data Collection 
This study is based on annual observations (that is, from 1990 – 2018) on the total number of  new HIV infections, that is, 
adults (ages 15+) and children (ages 0 – 14) [denoted as J] in Togo. Out-of-sample forecasts will cover the period 2019 – 
2030. All the data was collected from the World Bank online database. 
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3.4 Diagnostic Tests & Model Evaluation 
3.4.1 The ADF Test in Levels 
Table 1: with intercept 
Variable ADF Statistic Probability Critical Values Conclusion 
J -0.393841 0.8972 -3.689194 @1% Non-stationary  
  -2.971853 @5% Non-stationary 
  -2.625121 @10% Non-stationary 
Table 1 shows that J is not stationary in levels. 
3.4.2 The ADF Test (at First Differences) 
Table 2: with intercept 
Variable ADF Statistic Probability Critical Values Conclusion 
∆J -2.529962 0.1198 -3.699871 @1% Non-stationary  
  -2.976263 @5% Non-stationary 
  -2.627420 @10% Non-stationary 
Table 2 indicates that J is not an I (1) variable.   
3.4.3 The ADF Test (at Second Differences) 
Table 3: with intercept 
Variable ADF Statistic Probability Critical Values Conclusion 
∆2𝐽 -3.838493 0.0077 -3.724070 @1% Stationary  
  -2.986225 @5% Stationary 
  -2.632604 @10% Stationary 
Table 3 indicates that J is an I (2) variable. 
3.4.4 Evaluation of ARIMA models (without a constant) 
Table 4: Evaluation of ARIMA Models (without a constant) 
Model AIC U ME RMSE MAPE 
ARIMA (1, 2, 1) 410.5753 0.62615 -89.298 432.16 3.4392 
ARIMA (1, 2, 0) 408.8656 0.61955 -95.228 434.55 3.3771 
ARIMA (0, 2, 1) 411.1869 0.64265 -94.645 454.82 3.3495 
ARIMA (2, 2, 0) 410.3296 0.63147 -82.379 430.13 3.4741 
ARIMA (0, 2, 2) 408.5350 0.61547 -69.79 416.48 3.3989 
A model with a lower AIC value is better than the one with a higher AIC value (Nyoni, 2018b) Similarly, the U statistic 
can be used to find a better model in the sense that it must lie between 0 and 1, of which the closer it is to 0, the better the 
forecast method (Nyoni, 2018a). In this research paper, only the AIC is used to select the optimal model. Therefore, the 
ARIMA (0, 2, 2) model is finally chosen.  
3.5 Residual & Stability Tests 
3.5.1 Correlogram of the Residuals of the ARIMA (0, 2, 2) Model 
Figure 1: Correlogram of the Residuals 
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Figure 1 indicates that the estimated parsimonious model is adequate because ACF and PACF lags are quite short and 
within the bands.  
3.5.2 Stability Test of the ARIMA (0, 2, 2) Model 















Inverse Roots of AR/MA Polynomial(s)
 
Since all the MA roots lie inside the unit circle, it implies that the estimated ARIMA process is (covariance) stationary; 
thus confirming that the ARIMA (0, 2, 2) model is stable. 
 3.5.3 Normality Test of the Residuals of the ARIMA (0, 2, 2) Model 
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Since the probability value of the chi-square statistic is insignificant, we reject the null hypothesis and conclude that the 
residuals of the ARIMA (0, 2, 2) model are normally distributed.    
4.0 FINDINGS OF THE STUDY 
4.1 Results Presentation1 
Table 5: Main Results 
ARIMA (0, 2, 2) Model: 
The chosen optimal model, the ARIMA (0, 2, 2) model can be expressed as follows: 
∆2𝐽𝑡 = −0.487163𝜇𝑡−1 + 0.412547𝜇𝑡−2………………………………………… . . ……… . . … . . [2] 
Variable Coefficient Standard Error z p-value 
𝛼1 -0.487163 0.175660 -2.773 0.0055*** 
𝛼2 0.412547 0.182468 2.261 0.0238** 
Table 9 shows the main results of the ARIMA (0, 2, 2) model.  
Forecast Graph 
Figure 4: Forecast Graph – In & Out-of-Sample Forecasts 
                                                     





















Test statistic for normality:
Chi-square(2) = 0.273 [0.8722]
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Figure 4 shows the in-and-out-of-sample forecasts of the J series. The out-of-sample forecasts cover the period 2019 – 
2030.   
Predicted J– Out-of-Sample Forecasts Only 
Table 6: Predicted J 
 Year Predicted J Standard Error 95% Confidence Interval 
2019 4791.08 414.121 (3979.41, 5602.74) 
2020 4558.17 750.996 (3086.25, 6030.10) 
2021 4325.27 1258.38 (1858.89, 6791.65) 
2022 4092.37 1877.18 (413.166, 7771.57) 
2023 3859.47 2584.29 (-1205.64, 8924.58) 
2024 3626.57 3367.71 (-2974.02, 10227.2) 
2025 3393.66 4219.75 (-4876.89, 11664.2) 
2026 3160.76 5134.85 (-6903.36, 13224.9) 
2027 2927.86 6108.72 (-9045.01, 14900.7) 
2028 2694.96 7137.88 (-11295.0, 16684.9) 
2029 2462.06 8219.42 (-13647.7, 18571.8) 
2030 2229.15 9350.87 (-16098.2, 20556.5) 
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Table 6 and figure 5 show the out-of-sample forecasts only. The total number of new HIV infections in Togo is projected 
to decline sharply by 53.5% from the estimated 4791 new infections in 2019 to approximately 2229 new infections by 
2030. 
5.0 CONCLUSION 
The study shows that the ARIMA (0, 2, 2) model is not only stable but also the most suitable model to forecast the total 
annual number of new HIV infections in Togo over the period 2019 – 2030. The model predicts a commendable decrease 
in the annual number of new HIV infections in Togo and this is quite encouraging for the country. The paper recommends 
that the government of Togo should continue scaling up HIV prevention and treatment access throughout the country. 
Special emphasis must be directed towards behavior change interventions such as increased condom use as well as 
reduction of sexual partners. Togo is a low circumcision country; therefore, it would be beneficial for the government to 
up scale voluntary medical male circumcision as an additional HIV prevention strategy.  
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